Grand Pharmacology Bundle

  • Registration Closed

This grand pharmacology bundle holds a wide variety of over 20 different critical primary care topics for prescribers, from pediatric pharmaceutical updates and safe prescribing in older adults, to a 2021 drug update. This bundle has it all. Topics include contraceptive management, polypharmacy, asthma guidelines, medical marijuana, HIV updates, hypertension, mood disorders, depression, dyslipidemia, diabetes management, and more.

Total Credits: 31.0 contact hours; 30.0 are pharmacology
Release Date: December 1, 2021
$775
  • Includes Credits

    Nurse Practitioners are on the front line in the role of treating adults with Type 2 Diabetes Mellitus. According to the CDC, more than 34 million Americans have diabetes (about 1 in 10), and approximately 90-95% of them have type 2 diabetes. Type 2 diabetes most often develops in people over age 45, but more and more often teens and young adults are also developing it. | 1.50 credits (1.50 pharmacology) | $37.50

  • Includes Credits

    This presentation will focus on these injectables to achieve the best possible esthetic and therapeutic outcomes. An understanding of facial anatomy, the aging process, and safety issues for injectable therapy is needed to diagnose and recommend aesthetic treatment plans. A review of neurotoxins and dermal fillers, including the mechanism of action, side effects, expected results, and complications with protocols will be discussed. | 1.00 credits (1.00 pharmacology) | $25

  • Includes Credits

    The Nurse Practitioner in the Primary Care setting is challenged in the treatment of ASCVD to provide the most up-to-date goals, treatment guidelines, and expectations for primary vs secondary prevention. This program will sift through the complicated updates of the past few years and allow the nurse practitioner to incorporate these into their practice. | 1.00 credits (1.00 pharmacology) | $25

  • Includes Credits

    Updates to the 2007 NAEPP/NHLBI asthma guidelines were published in late 2020. These updates cover five specific areas of asthma evaluation and management but leave many areas without updates. To fill in those gaps, many clinicians use the GINA guidelines produced in the UK. In this presentation, the new NAEPP/NHLBI updates will be reviewed and compared to older recommendations and to the broader recommendations from GINA. | 1.50 credits (1.25 pharmacology) | $37.50

  • Includes Credits

    This presentation will review the newest options and recommendations for contraceptive management. We will cover newly available methods as well as those more established. The presentation will also cover strategies to improve contraception adherence including common mistakes patients make and how to address them. | 1.50 credits (1.25 pharmacology) | $37.50

  • Includes Credits

    This session examines polypharmacy trends and implications. It describes what is currently being done and explores additional prospective solutions. A list of resources is provided to help empower nurse practitioners to consider and incorporate principles of mindful prescribing. | 1.00 credits (1.00 pharmacology) | $25

  • Includes Credits

    Keeping up with new medications, particularly given the recent trend towards direct-to-consumer advertising, is one of the true challenges of primary care. Dr. Wright will focus on the top new, widely used medications, including their appropriate uses, adverse effects, and drug interactions. | 1.50 credits (1.50 pharmacology) | $37.50

  • Includes Credits

    This presentation reviews critical elements of diagnosis, important considerations in pharmacotherapy, and utilizes a case study approach to analyze the best treatment regimens. | 1.50 credits (1.50 pharmacology) | $37.50

  • Includes Credits

    This presentation reviews the pathophysiology of ADD as the target of pharmacotherapy. Pharmacotherapeutics of psychostimulants, norepinephrine reuptake inhibitors, antiadrenergic agonists, and wakefulness agents are analyzed, with emphasis on indications and efficacies for each. Case studies are then used to evaluate best-practice options in a variety of clinical scenarios including pediatric, adult and psychostimulants contraindicated. | 1.50 credits (1.50 pharmacology) | $37.50

  • Includes Credits

    The focus of this program is the analysis and application of appropriate pharmacotherapy for the treatment of bipolar depression, bipolar mania, cyclothymia, and prevention of relapse. Drug selection, indications, and important safety issues are analyzed in a case study presentation. | 1.50 credits (1.50 pharmacology) | $37.50